Anagrelid
Anagrelid Nordic is used to reduce the increased number of platelets (thrombocytes) in patients with essential thrombocythemia, which occurs when the body produces too many blood platelets. A large increase in the number of blood platelets can cause problems with blood circulation (circulatory disorders) and blood clotting. Reducing the number of platelets reduces the risk of serious complications.
Before starting treatment with Anagrelid Nordic, consult your doctor:
When taking Anagrelid Nordic with acetylsalicylic acid (a substance also known as aspirin, found in many pain-relieving and fever-reducing medicines, as well as in medicines that prevent blood clotting), there is an increased risk of serious bleeding (see "Anagrelid Nordic and other medicines").
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take. Inform your doctor if you are taking any of the following medicines:
The effect of Anagrelid Nordic or the mentioned medicines may be impaired if taken together. If in doubt, consult your doctor or pharmacist.
Food delays the absorption of Anagrelid Nordic, but does not significantly affect its potency. You should not drink grapefruit juice, as it may prolong the elimination of the medicine from the body.
If you are pregnant or plan to become pregnant, inform your doctor. Pregnant women should not take Anagrelid Nordic. Women of childbearing age should use effective contraception while taking Anagrelid Nordic. If you are breastfeeding or plan to breastfeed, inform your doctor. You should not take Anagrelid Nordic while breastfeeding. You should stop breastfeeding if you take Anagrelid Nordic.
Some patients taking Anagrelid Nordic have experienced dizziness. If you experience dizziness, do not drive or operate machinery.
This medicine contains lactose. If you have been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be taken exactly as your doctor has instructed. Your doctor will determine the most suitable dose for you. The usual initial dose of Anagrelid Nordic is 0.5 mg to 1 mg once daily for at least one week. After this period, your doctor may increase or decrease the number of tablets to determine the most suitable dose for you, which will provide the most effective treatment. The maximum dose is 5 mg per day. The tablet can be divided into equal doses. Do not take more tablets than your doctor has prescribed.
Since experience with Anagrelid Nordic in children and adolescents is limited, this medicine should not be used in children and adolescents under 18 years of age.
If you have liver or kidney disease, your doctor will decide whether you can be treated with Anagrelid Nordic.
Anagrelid Nordic tablets should be taken with a sufficient amount of liquid.
If you have taken more Anagrelid Nordic than prescribed or if someone else has taken your medicine, immediately inform your doctor or pharmacist. You should show the packaging of Anagrelid Nordic. High doses of the medicine can lead to a decrease in blood pressure, accompanied by dizziness, nausea, and heart rhythm disorders.
You should take the tablet as soon as you remember. The next dose should be taken at the usual time. Do not take a double dose to make up for the missed dose.
Do not stop taking Anagrelid Nordic without consulting your doctor. After stopping treatment with Anagrelid Nordic, the platelet count will return to pre-treatment values within 14 days. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Anagrelid Nordic can cause side effects, although not everybody gets them. If you experience any serious side effects or any side effects not listed in this package leaflet, inform your doctor or pharmacist. Serious side effects:
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very common (may affect more than 1 in 10 people):
Headache.
Common (may affect up to 1 in 10 people):
Decreased red blood cell count (anemia), bleeding under the skin, swelling, dizziness of inner ear origin, insomnia, abnormal sensations or feelings, such as tingling or "pins and needles", rapid heartbeat, irregular or strong heartbeats (palpitations), high blood pressure, nosebleeds, diarrhea, nausea, indigestion, rash, back pain, fatigue.
Uncommon (may affect up to 1 in 100 people):
Decreased platelet count (thrombocytopenia), bleeding, bruising, weight gain, depression, nervousness, dry mouth, migraine, conjunctivitis, vision disorders, ringing in the ears (tinnitus), fainting, shortness of breath or difficulty breathing, pneumonia, increased blood pressure in the lungs, causing symptoms such as shortness of breath, fatigue, chest pain, or swelling, vomiting, flatulence, stomach pain, constipation, hair loss, skin itching, joint pain, muscle pain, urinary tract infection, pain, weakness.
Rare (may affect up to 1 in 1,000 people):
Severe chest pain (angina pectoris), dizziness when standing up (especially from a sitting or lying position), loss of appetite, stomach inflammation (symptoms include pain, nausea, vomiting), fluid accumulation around the lungs, pneumonia, asthma, increased need to urinate at night, increased liver enzyme activity, flu-like symptoms, chills, general feeling of being unwell.
Side effects with unknown frequency:
Irregular heartbeat (torsades de pointes), respiratory disease causing scarring in lung tissue (symptoms include shortness of breath), kidney inflammation (interstitial nephritis).
If you experience any side effects, including those not listed in this package leaflet, inform your doctor or pharmacist. You can also report side effects directly to the Department of Medicines Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl. You can also report side effects to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Store the blister pack in the outer packaging to protect from light. Store the bottle tightly closed to protect from light. Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the bottle, carton, or blister after "EXP". The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is anagrelide.
Anagrelid Nordic, 0.5 mg:Each tablet contains 0.5 mg of anagrelide (as anagrelide hydrochloride monohydrate)
Anagrelid Nordic, 0.75 mg:Each tablet contains 0.75 mg of anagrelide (as anagrelide hydrochloride monohydrate)
Anagrelid Nordic, 1 mg:Each tablet contains 1 mg of anagrelide (as anagrelide hydrochloride monohydrate)
Other ingredients are: lactose anhydrous, povidone (K30), crospovidone (type B), microcrystalline cellulose, and magnesium stearate.
Anagrelid Nordic, 0.5 mg, are white to almost white, round tablets, approximately 6.5 mm in diameter, with "0.5" engraved on one side and a score line on the other side.
Anagrelid Nordic, 0.75 mg, are white to almost white, round tablets, approximately 8 mm in diameter, with "0.75" engraved on one side and a score line on the other side.
Anagrelid Nordic, 1 mg, are white to almost white, round tablets, approximately 9 mm in diameter, with "1.0" engraved on one side and a score line on the other side.
The tablets can be divided into equal doses.
Polyethylene bottles with child-resistant closures, containing 100 tablets.
PVC/PVDC/Aluminum blisters in packs containing 100 tablets.
Nordic Group B.V.
Siriusdreef 41
2132 WT Hoofddorp
Netherlands
QPharma AB
Agneslundsvägen 27
21215 Malmö
Sweden
Austria:
Anagrelid Nordic 0.5 mg Tabletten
Anagrelid Nordic 0.75 mg Tabletten
Anagrelid Nordic 1 mg Tabletten
Bulgaria:
Anagrelid Nordic 0.5 mg tablets
Анагрелид Нордик 0.5 mg, таблетки
Anagrelid Nordic 0.75 mg tablets
Анагрелид Нордик 0.75 mg, таблетки
Anagrelid Nordic 1 mg tablets
Анагрелид Нордик 1 mg, таблетки
Italy:
REDESK
Czech Republic:
Anagrelid Nordic
Poland:
Anagrelid Nordic
Romania:
Anagrelidă Nordic 0.5 mg, comprimate
Anagrelidă Nordic 0.75 mg, comprimate
Anagrelidă Nordic 1.0 mg, comprimate
Slovakia:
Anagrelid Nordic 0.5 mg tablets
Anagrelid Nordic 0.75 mg tablets
Anagrelid Nordic 1.0 mg tablets
Date of last revision of the package leaflet:2020-04-08
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.